NSE · GKSL
Gujarat Kidney And Super Speciality Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,393
of 5,096 stocks
▼ 181W
Peak #1,375 · 21 Sep 2026
A smallcap name in Healthcare, Gujarat Kidney And Super Speciality Limited carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and remains firmly promoter-controlled, with promoters holding 71%.
Market Cap
1,378.42 Cr
P/E Ratio
70.21
P/B Ratio
5.41
ROE
6.60%
ROCE
8.57%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 34.29 Cr | 30.58 Cr | 23.25 Cr | 12.93 Cr |
| Net Profit | 5.32 Cr | 4.83 Cr | 3.71 Cr | 2.88 Cr |
| EPS | 0.66 | 0.81 | 0.52 | 0.52 |
| Operating Profit | 7.63 Cr | 5.50 Cr | 5.63 Cr | 4.31 Cr |
Shareholding pattern
Promoter
71.45%
Public
28.55%
Mutual fund holdings
₹0.01
Cr total
2
Schemes
2
Fund Houses
₹0.01 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.01 Cr (65.3%)
Bandhan Mutual Fund₹0.00 Cr (34.7%)
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.